Related references
Note: Only part of the references are listed.Safety and efficacy of long-term diflunisal administration in hereditary transthyretin (ATTR) amyloidosis
Yoshiki Sekijima et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2015)
Nomenclature 2014: Amyloid fibril proteins and clinical classification of the amyloidosis
Jean D. Sipe et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2014)
Recent progress in the understanding and treatment of transthyretin amyloidosis
Y. Sekijima
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2014)
Proteolytic cleavage of Ser52Pro variant transthyretin triggers its amyloid fibrillogenesis
P. Patrizia Mangione et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Amyloid fibrils containing fragmented ATTR may be the standard fibril composition in ATTR amyloidosis
Elisabet Ihse et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2013)
Age-Related Oxidative Modifications of Transthyretin Modulate Its Amyloidogenicity
Lei Zhao et al.
BIOCHEMISTRY (2013)
Repurposing Diflunisal for Familial Amyloid Polyneuropathy A Randomized Clinical Trial
John L. Berk et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy
Teresa Coelho et al.
JOURNAL OF NEUROLOGY (2013)
Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis
Teresa Coelho et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Guideline of transthyretin-related hereditary amyloidosis for clinicians
Yukio Ando et al.
ORPHANET JOURNAL OF RARE DISEASES (2013)
Effects of Tafamidis on Transthyretin Stabilization and Clinical Outcomes in Patients with Non-Val30Met Transthyretin Amyloidosis
Giampaolo Merlini et al.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2013)
Antibody therapy for familial amyloidotic polyneuropathy
Yu Su et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2012)
Doxycycline plus tauroursodeoxycholic acid for transthyretin amyloidosis: a phase II study
Laura Obici et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2012)
Clinical development of an antisense therapy for the treatment of transthyretin-associated polyneuropathy
Elizabeth J. Ackermann et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2012)
Natural history of transthyretin Val30Met familial amyloid polyneuropathy: analysis of late-onset cases from non-endemic areas
Haruki Koike et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)
Tafamidis for transthyretin familial amyloid polyneuropathy A randomized, controlled trial
Teresa Coelho et al.
NEUROLOGY (2012)
Long-term survival after liver transplantation in patients with familial amyloid polyneuropathy
T. Yamashita et al.
NEUROLOGY (2012)
Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade
Christine E. Bulawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Long-term data from the Familial Amyloidotic Polyneuropathy World Transplant Registry (FAPWTR)
H. E. Wilczek et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2011)
Diagnostic value of abdominal wall fat pad biopsy in senile systemic amyloidosis
Shu-ichi Ikeda et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2011)
Sulfated Glycosaminoglycans Accelerate Transthyretin Amyloidogenesis by Quaternary Structural Conversion
Steve Bourgault et al.
BIOCHEMISTRY (2011)
High prevalence of wild-type transthyretin deposition in patients with idiopathic carpal tunnel syndrome: a common cause of carpal tunnel syndrome in the elderly
Yoshiki Sekijima et al.
HUMAN PATHOLOGY (2011)
Clinicopathological features of senile systemic amyloidosis: an ante- and post-mortem study
Mitsuharu Ueda et al.
MODERN PATHOLOGY (2011)
Suppression of choroid plexus transthyretin levels by antisense oligonucleotide treatment
Merrill D. Benson et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2010)
Antibodies to human serum amyloid P component eliminate visceral amyloid deposits
Karl Bodin et al.
NATURE (2010)
Liver Transplantation for Familial Amyloidotic Polyneuropathy: Impact on Swedish Patients' Survival
Sadahisa Okamoto et al.
LIVER TRANSPLANTATION (2009)
Prefibrillar transthyretin oligomers and cold stored native tetrameric transthyretin are cytotoxic in cell culture
Karin Sorgjerd et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Pathogenesis of and Therapeutic Strategies to Ameliorate the Transthyretin Amyloidoses
Yoshiki Sekijima et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Marked regression of abdominal fat amyloid in patients with familial amyloid polyneuropathy during long-term follow-up after liver transplantation
Ayako Tsuchiya et al.
LIVER TRANSPLANTATION (2008)
Liver transplantation for familial amyloidotic polyneuropathy (FAP):: A single-center experience over 16 years
S. Yamamoto et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Transthyretin oligomers induce calcium influx via voltage-gated calcium channels
Xu Hou et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Diflunisal stabilizes familial amyloid polyneuropathy-associated transthyretin variant tetramers in serum against dissociation required for amyloidogenesis
Kana Tojo et al.
NEUROSCIENCE RESEARCH (2006)
Orally administered diflunisal stabilizes transthyretin against dissociation required for amyloidogenesis
Yoshiki Sekijima et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2006)
Targeted suppression of an amyloidogenic transthyretin with antisense oligonucleotides
MD Benson et al.
MUSCLE & NERVE (2006)
Activation of ERK1/2 MAP kinases in familial amyloidotic polyneuropathy
FA Monteiro et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Immunization in familial amyloidotic polyneuropathy: counteracting deposition by immunization with a Y78F TTR mutant
H Terazaki et al.
LABORATORY INVESTIGATION (2006)
A prospective evaluation of the transthyretin Ile122 allele frequency in an African-American population
T Yamashita et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2005)
Amyloid deposits in transthyretin-derived amyloidosis:: cleaved transthyretin is associated with distinct amyloid morphology
J Bergström et al.
JOURNAL OF PATHOLOGY (2005)
The biological and chemical basis for tissue-selective amyloid disease
Y Sekijima et al.
CELL (2005)
Tissue damage in the amyloidoses: Transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture
N Reixach et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
End-stage renal disease and dialysis in hereditary amyloidosis TTR V30M:: presentation, survival and prognostic factors
L Lobato et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2004)
Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: Results from the familial amyloidotic polyneuropathy world transplant registry
G Herlenius et al.
TRANSPLANTATION (2004)
Pathology of early- vs late-onset TTR Met30 familial amyloid polyneuropathy
H Koike et al.
NEUROLOGY (2004)
Transthyretin aggregation under partially denaturing conditions is a downhill polymerization
AR Hurshman et al.
BIOCHEMISTRY (2004)
Native state stabilization by NSAIDs inhibits transthyretin amyloidogenesis from the most common familial disease variants
SR Miller et al.
LABORATORY INVESTIGATION (2004)
Prevention of transthyretin amyloid disease by changing protein misfolding energetics
P Hammarström et al.
SCIENCE (2003)
Trans-suppression of misfolding in an amyloid disease
P Hammarström et al.
SCIENCE (2001)
Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin
M Yazaki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Share Paper
